Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1984 Jan;25(1):113–117. doi: 10.1128/aac.25.1.113

Synthesis and biological activities of 4"-deoxy-4"-sulfonamido-oleandomycin derivatives.

G M Bright, A R English, A A Nagel, J A Retsema, F C Sciavolino
PMCID: PMC185446  PMID: 6703674

Abstract

Chemical modification of the macrolide antibiotic oleandomycin (C-1) is described. Reductive amination of 11-acetyl-4"-deoxy-4"-oxo-oleandomycin (C-6) with ammonium acetate provides amino-oleandomycin derivative C-7 in which the 4"-amine is oriented in the axial configuration. The structure-activity relationship of a series of 4"-sulfonamide analogs prepared from amino-oleandomycin derivative C-7 is discussed. Noteworthy is the significant in vitro potency enhancement of the para-chlorobenzenesulfonamide analog C-12 over that of the parent oleandomycin. The absolute configuration of the 4"-amino-oleandomycin derivative C-7 was established through X-ray analysis of the para-iodobenzenesulfonamide analog C-14.

Full text

PDF
113

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CELMER W. D., ELS H., MURAI K. Oleandomycin derivatives, preparation and characterization. Antibiot Annu. 1957;5:476–483. [PubMed] [Google Scholar]
  2. CELMER W. D. MACROLIDE STEREOCHEMISTRY. I. THE TOTAL ABSOLUTE CONFIGURATION OF OLEANDOMYCIN. J Am Chem Soc. 1965 Apr 20;87:1797–1799. doi: 10.1021/ja01086a036. [DOI] [PubMed] [Google Scholar]
  3. CELMER W. D. Triacetyloleandomycin: biochemical correlations. Antibiot Annu. 1958;6:277–283. [PubMed] [Google Scholar]
  4. ENGLISH A. R., McBRIDE T. J. Laboratory evaluation of partially-acetylated esters of oleandomycin. Proc Soc Exp Biol Med. 1959 Apr;100(4):880–884. doi: 10.3181/00379727-100-24812. [DOI] [PubMed] [Google Scholar]
  5. ENGLISH A. R. Oleandomycin: cross-resistance studies with clinical isolates of Micrococcus pyogenes var. aureus. Antibiot Annu. 1957;5:756–759. [PubMed] [Google Scholar]
  6. English A. R., Retsema J. A., Girard A. E., Schelkly W., Lynch J. E. Evaluation of three 4"-deoxy-4"-sulfonamido-oleandomycin derivatives with erythromycin-like antibacterial potency. Antimicrob Agents Chemother. 1984 Jan;25(1):118–122. doi: 10.1128/aac.25.1.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. English A. R., Retsema J. A., Ray V. A., Lynch J. E. Carbenicillin indanyl sodium, an orally active derivative of carbenicillin. Antimicrob Agents Chemother. 1972 Mar;1(3):185–191. doi: 10.1128/aac.1.3.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. JONES W. F., Jr, FINLAND M. Susceptibility of enterococci and of hemolytic streptococci of groups A, B, C, and G to five new antibiotics in vitro. Am J Clin Pathol. 1957 May;27(5):528–533. doi: 10.1093/ajcp/27.5.528. [DOI] [PubMed] [Google Scholar]
  9. Pestka S., Lemahieu R. A. Effect of erythromycin analogues on binding of [14C]erythromycin to Escherichia coli ribosomes. Antimicrob Agents Chemother. 1974 Oct;6(4):479–488. doi: 10.1128/aac.6.4.479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Semenitz E. The antibacterial activity of oleandomycin and erythromycin--a comparative investigation using microcalorimetry and MIC determination. J Antimicrob Chemother. 1978 Sep;4(5):455–457. doi: 10.1093/jac/4.5.455. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES